The Diako Lab was honored to represent Diako Lab at the 2025 San Antonio Breast Cancer Symposium (SABCS) — one of the world’s leading conferences dedicated to advancing breast cancer research, treatment, and prevention.
Our team members — Jake Lehle, Mohadeseh Soleimanpour-moghadam, and Niloofar Haghjoo — had the privilege of presenting their latest findings on the role of APOBEC3 in cancer development.
This symposium brought together scientists, clinicians, and innovators from across the globe to exchange knowledge and push forward the boundaries of cancer research. We are proud to have contributed to this important dialogue and to share our work with such an inspiring community.
